Other Events ·
Incyte shareholders elect eight directors, approve advisory compensation and ratify Ernst & Young as auditor
INCYIncyte Corp
Incyte Corporation held its Annual Meeting of Shareholders on June 8, 2026, where shareholders elected eight directors, approved non-binding advisory compensation for named executive officers, and ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. Incyte Corporation is a biotechnology company that develops and commercializes therapeutic products.